Ignite Creation Date:
2024-05-05 @ 5:11 PM
Last Modification Date:
2024-10-26 @ 9:29 AM
Study NCT ID:
NCT00409240
Status:
COMPLETED
Last Update Posted:
2014-04-11
First Post:
2006-12-07
Brief Title:
Multi-Targeted Cardiac Risk Intervention in Type 2 Diabetes
Sponsor:
Providence VA Medical Center
Organization:
Providence VA Medical Center
Study Overview
Official Title:
Multi-Targeted Cardiac Risk Intervention in Type 2 Diabetes
Status:
COMPLETED
Status Verified Date:
2014-03
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Our study intends to test the efficacy of pharmacist-led group interventions on a weekly basis for 4-weeks then on a monthly basis for 5 additional months to achieve concomitant reductions in hemoglobin A1c lipids and blood pressure
Detailed Description:
Our project intends to study the 6-month efficacy of a pharmacist-led group intervention program that simultaneously target diabetes hypertension and dyslipidemia We hypothesize that pharmacist-led group interventions on a weekly basis for 4-weeks then on a monthly basis for 5 additional months may achieve concomitant reductions in hemoglobin A1c lipids and blood pressure We are proposing a pilot randomized controlled study to test the efficacy and feasibility of this approach
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None